The CDSCO flagged certain cough syrup batches as spurious and identified 112 drugs as not meeting quality standards in ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

The FDA is pursuing leucovorin as a potential treatment for autism spectrum disorder. The medication is currently used as a cancer drug, among other things. Preliminary data suggests the medication ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images President Trump on Tuesday announced the first of ...

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers. By Rebecca Robbins ...

President Donald Trump on Tuesday announced the creation of “TrumpRx,” a direct-to-consumer website where customers can buy drugs directly, as well as an agreement with pharmaceutical manufacturer ...

President Trump’s strategy to lower prescription drug prices will be put to the test as drugmakers must now commit to the terms of his “Most Favored Nation” pricing plan or face unspecified actions ...

President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...

President Donald Trump on Tuesday announced a multipronged effort aimed at lowering drug costs in the United States, including the creation of a “TrumpRx” direct-to-consumer website where Americans ...

President Donald Trump announced Tuesday that his administration has reached a deal with Pfizer for it to voluntarily sell its drugs at lower prices to Medicaid patients. As part of the deal, Trump ...

Steve Ubl is president and chief executive of PhRMA, a trade group representing pharmaceutical and biotechnology companies in the United States. President Donald Trump is right to ask why Americans ...

It’s becoming increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices. The sector has long traded at a ...